Diligence memo · auto-generated · as of July 2, 2026
MS Biotech Holdings, Inc.
MS Biotech Holdings, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
MS Biotech Holdings, Inc. operates in Agriculture, based in LITTLETON.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
MS Biotech Holdings, Inc. has raised $59M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $59M on 2018-09-26.
Most recent recorded round closed around 2018-09-26.
Valuation (modeled)modeled
Provath models MS Biotech Holdings, Inc. at approximately $584M (range $217M–$1.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.24× the median modeled value of Series C Agriculture companies in 2016–2018 (9 peers) — value vs value, same stage and era. Within the normal band (124% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 7.8 yr ago; this sector typically re-raises about every 11 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 94% of Agriculture peers (1056 compared).
Modeled value ranks above 96% of those peers.
Closest niche peers: Cresco Labs, LLC, Cresco Labs Finco Ltd., Cibus Global, Ltd., Calyxt, Inc., WholeStone Farms II, LLC.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.